Anxo Pharmaceutical Co., Ltd. (6677.TWO)

TWD 24.2

(-0.21%)

Market Cap (In TWD)

1.34 Billion

Revenue (In TWD)

939.94 Million

Net Income (In TWD)

21.86 Million

Avg. Volume

70.8 Thousand

Currency
TWD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
23.9-51.0
PE
-
EPS
-
Beta Value
-0.098
ISIN
TW0006677008
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Linquan Yan
Employee Count
-
Website
https://www.anxo.com.tw
Ipo Date
2018-06-27
Details
Anxo Pharmaceutical Co., Ltd., a specialty pharmaceutical company, develops, manufactures, and sells pharmaceutical products for medical professionals and patients in Taiwan and internationally. The company offers prescription and over the counter drugs in various therapeutic areas, such as cardiovascular, metabolism, CNS, diabetic, respiratory, anti-infection, dermatology, nephrology, urology, orthopedics, etc. It also offers drugs for antidiabetic/dyslipidaemic agents, cardiovascular/circulatory system, nervous system, hepatology/gastroenterology, anti-infectives/anti-viruses, hemodialysis/urinary system, respiratory system/antihistamine, analgesics, and others; and injections. The company was founded in 2003 and is headquartered in Taipei, Taiwan.